Pharmacological Treatment of Generalized Anxiety Disorder
作者： David S. Baldwin , Khalil I. Ajel , Matthew Garner
DOI: 10.1007/7854_2009_2
关键词: Generalized anxiety disorder 、 Psychology 、 Reuptake inhibitor 、 Intensive care medicine 、 Serotonin reuptake inhibitor 、 Psychiatry 、 Tolerability 、 Relapse prevention 、 Worry 、 Adverse effect 、 Pregabalin
摘要: … A PubMed search was completed using the terms: ‘generalized anxiety disorder AND treatment’ and ‘generalized anxiety disorder AND therapy’. Additional pivotal trials were included …
springer.com
sci-hub.se 参考文章(90)
Moira A. Rynn, Mark A. Riddle, Paul P. Yeung, Nadia R. Kunz, Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. American Journal of Psychiatry. ,vol. 164, pp. 290- 300 ,(2007) , 10.1176/AJP.2007.164.2.290
Stuart Montgomery, Krai Chatamra, Lynne Pauer, Ed Whalen, Francesca Baldinetti, Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. British Journal of Psychiatry. ,vol. 193, pp. 389- 394 ,(2008) , 10.1192/BJP.BP.107.037788
Steven E. Bruce, Kimberly A. Yonkers, Michael W. Otto, Jane L. Eisen, Risa B. Weisberg, Maria Pagano, M. Tracie Shea, Martin B. Keller, Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study American Journal of Psychiatry. ,vol. 162, pp. 1179- 1187 ,(2005) , 10.1176/APPI.AJP.162.6.1179
Christer Allgulander, David Hackett, Eliseo Salinas, Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study. British Journal of Psychiatry. ,vol. 179, pp. 15- 22 ,(2001) , 10.1192/BJP.179.1.15
R. W. Downing, K. Rickels, Early treatment response in anxious outpatients treated with diazepam. Acta Psychiatrica Scandinavica. ,vol. 72, pp. 522- 528 ,(1985) , 10.1111/J.1600-0447.1985.TB02649.X
Peter Tyrer, David Baldwin, Generalised anxiety disorder The Lancet. ,vol. 368, pp. 2156- 2166 ,(2006) , 10.1016/S0140-6736(06)69865-6
Atul C. Pande, Jerri G. Crockatt, Douglas E. Feltner, Carol A. Janney, Ward T. Smith, Richard Weisler, Peter D. Londborg, Robert J. Bielski, Dan L. Zimbroff, Jonathan R.T. Davidson, Maria Liu-Dumaw, Pregabalin in generalized anxiety disorder: a placebo-controlled trial. American Journal of Psychiatry. ,vol. 160, pp. 533- 540 ,(2003) , 10.1176/APPI.AJP.160.3.533
John R Geddes, Stuart M Carney, Christina Davies, Toshiaki A Furukawa, David J Kupfer, Ellen Frank, Guy M Goodwin, Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review The Lancet. ,vol. 361, pp. 653- 661 ,(2003) , 10.1016/S0140-6736(03)12599-8
David Baldwin, Ricardo A Moreno, Mike Briley, None, Resolution of sexual dysfunction during acute treatment of major depression with milnacipran. Human Psychopharmacology-clinical and Experimental. ,vol. 23, pp. 527- 532 ,(2008) , 10.1002/HUP.955
G. Kinrys, D. Vasconcelos e Sa, F. Nery, Adjunctive zonisamide for treatment refractory anxiety. International Journal of Clinical Practice. ,vol. 61, pp. 1050- 1053 ,(2007) , 10.1111/J.1742-1241.2007.01365.X